| Mark S Reinhard, RPH | |
|
762 Little Coal River Rd, Alum Creek, WV 25003-9262 | |
| (304) 756-2160 | |
| (304) 756-1262 |
| Full Name | Mark S Reinhard |
|---|---|
| Gender | Male |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 762 Little Coal River Rd, Alum Creek, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154767648 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | RP0007418 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark S Reinhard, RPH 5013 Bennington Dr, Cross Lanes, WV 25313-2054 Ph: (804) 640-2198 | Mark S Reinhard, RPH 762 Little Coal River Rd, Alum Creek, WV 25003-9262 Ph: (304) 756-2160 |
News Archive
For the last century, inflammatory bowel disease (IBD) has been a challenge for patients and the medical community in the western world. New research published today in The Lancet by Dr. Gilaad Kaplan shows that countries outside the western world may now be facing the same pattern of increasing IBD rates.
Torrance Marriott Redondo Beach hopes to share the art of giving by hosting an upcoming silent auction. Donated by local artist Bridget Hardenbrook, "Koi Commotion" will be on display from May 30, 2015, through 2 p.m. June 7, 2015.
New research shows liver transplantation candidates without hepatocellular carcinoma (HCC) derive a greater survival benefit from a living donor liver transplant (LDLT) than waiting for a deceased donor liver transplant.
Talecris Biotherapeutics, Inc. announced today that it was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the development of an aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to treat congenital alpha1-antitrypsin (AAT) deficiency. AAT deficiency is a chronic, hereditary condition that increases the risk of certain diseases, especially emphysema, which typically emerges in the fourth decade of life. Currently, there are no approved, inhaled treatments available for the treatment of AAT deficiency.
› Verified 7 days ago
Dr. Jeffrey Fulks, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 762 Little Coal River Rd, Alum Creek, WV 25003 Phone: 304-756-1260 Fax: 304-756-1262 |